Our study demonstrates that chronic ATRA treatment upregulates hypothalamic RARα and CRH, key regulators of the hypothalamic–pituitary–adrenal (HPA) axis, leading to depression-like behaviors in rats. The gene discussed is RARA; the disease is depressive symptom measurement.